148 related articles for article (PubMed ID: 20545727)
1. Comparison of SurePath® and ThinPrep® liquid-based cervical cytology using positive predictive value, atypical predictive value and total predictive value as performance indicators.
Wright PK; Marshall J; Desai M
Cytopathology; 2010 Dec; 21(6):374-8. PubMed ID: 20545727
[TBL] [Abstract][Full Text] [Related]
2. Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates.
Rozemeijer K; Penning C; Siebers AG; Naber SK; Matthijsse SM; van Ballegooijen M; van Kemenade FJ; de Kok IM
Cancer Causes Control; 2016 Jan; 27(1):15-25. PubMed ID: 26458884
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
[TBL] [Abstract][Full Text] [Related]
4. Performance of the CellSolutions Glucyte liquid-based cytology in comparison with the ThinPrep and SurePath methods.
Alaghehbandan R
Acta Cytol; 2013; 57(2):189-97. PubMed ID: 23407055
[TBL] [Abstract][Full Text] [Related]
5. Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark.
Rebolj M; Rask J; van Ballegooijen M; Kirschner B; Rozemeijer K; Bonde J; Rygaard C; Lynge E
Br J Cancer; 2015 Nov; 113(9):1259-74. PubMed ID: 26448176
[TBL] [Abstract][Full Text] [Related]
6. Proposed Sheffield quantitative criteria in cervical cytology to assist the grading of squamous cell dyskaryosis, as the British Society for Clinical Cytology definitions require amendment.
Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
Cytopathology; 2005 Aug; 16(4):179-92. PubMed ID: 16048504
[TBL] [Abstract][Full Text] [Related]
7. Comparison between Conventional Cytology and Liquid-Based Cytology in the Tertiary Brazilian Navy Hospital in Rio de Janeiro.
de Oliveira ACA; Domingues MF; Neufeld PM; Fleury M; Nogueira Neto JF
Acta Cytol; 2020; 64(6):539-546. PubMed ID: 32516778
[TBL] [Abstract][Full Text] [Related]
8. Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice.
Cox JT
J Natl Compr Canc Netw; 2004 Nov; 2(6):597-611. PubMed ID: 19780303
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.
Rozemeijer K; Naber SK; Penning C; Overbeek LI; Looman CW; de Kok IM; Matthijsse SM; Rebolj M; van Kemenade FJ; van Ballegooijen M
BMJ; 2017 Feb; 356():j504. PubMed ID: 28196844
[No Abstract] [Full Text] [Related]
10. A randomised comparison of SurePath liquid-based cytology and conventional smear cytology in a colposcopy clinic setting.
Sykes PH; Harker DY; Miller A; Whitehead M; Neal H; Wells JE; Peddie D
BJOG; 2008 Oct; 115(11):1375-81. PubMed ID: 18823488
[TBL] [Abstract][Full Text] [Related]
11. Prospective parallel randomized trial of the MultiCyte™ ThinPrep(®) imaging system: the Scottish experience.
Palmer TJ; Nicoll SM; McKean ME; Park AJ; Bishop D; Baker L; Imrie JE
Cytopathology; 2013 Aug; 24(4):235-45. PubMed ID: 22616770
[TBL] [Abstract][Full Text] [Related]
12. Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis.
Fontaine D; Narine N; Naugler C
BMJ Open; 2012; 2(2):e000847. PubMed ID: 22505312
[TBL] [Abstract][Full Text] [Related]
13. Can an inadequate cervical cytology sample in ThinPrep be converted to a satisfactory sample by processing it with a SurePath preparation?
Sørbye SW; Pedersen MK; Ekeberg B; Williams MEJ; Sauer T; Chen Y
Cytojournal; 2017; 14():20. PubMed ID: 28900466
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cytology and histology results in English cervical screening laboratories before and after liquid-based cytology conversion: do the data provide evidence for a single category of high-grade dyskaryosis?
Blanks RG; Kelly RS
Cytopathology; 2010 Dec; 21(6):368-73. PubMed ID: 20955376
[TBL] [Abstract][Full Text] [Related]
15. Liquid-based cytology versus conventional cytology for detection of uterine cervical lesions: a prospective observational study.
Nishio H; Iwata T; Nomura H; Morisada T; Takeshima N; Takano H; Sasaki H; Nakatani E; Teramukai S; Aoki D
Jpn J Clin Oncol; 2018 Jun; 48(6):522-528. PubMed ID: 29668969
[TBL] [Abstract][Full Text] [Related]
16. Guidance on liquid-based cytology system conversion training: a secondary publication.
Wilson A
Cytopathology; 2016 Oct; 27(5):331-4. PubMed ID: 27650602
[TBL] [Abstract][Full Text] [Related]
17. Liquid-based cytology in the fine needle aspiration of parathyroid lesions: a comparison study with the conventional smear, ThinPrep, and SurePath.
Park GS; Lee SH; Jung SL; Jung CK
Int J Clin Exp Pathol; 2015; 8(10):12160-8. PubMed ID: 26722400
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
19. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
20. An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia.
Thiryayi SA; Marshall J; Rana DN
Cytopathology; 2010 Aug; 21(4):223-8. PubMed ID: 19843139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
